It is designed to help you identify the specific gaps in your routine and provide a tailored plan that fits your unique goals
DOI: 10.1016/j.ajcnut.2025.02.012 Bartimoccia, S., Cammisotto, V., Nocella, C., et al
We provide new evidence that treatment with semaglutide 2.4 mg weekly results in clinically relevant weight reduction
As of 2024, over 2% of Americans use GLP-1s for overweight/obesity, and around 4% use them overall (for any indication), with nearly half of users using them for weight loss
Autism research is in crisis: a mixed method study of researchers constructions of autistic people and autism research
Mental preparation for the return of normal hunger is as important as the pharmacological taper itself